← Browse by Condition
Medical Condition

venous thromboembolism

Total Trials
7
Recruiting Now
7
Trial Phases
Phase 3

ClinicalMetric tracks all active clinical trials for venous thromboembolism sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — venous thromboembolism Clinical Trials

How many clinical trials are currently recruiting for venous thromboembolism?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for venous thromboembolism, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for venous thromboembolism?
venous thromboembolism research spans Phase 3 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a venous thromboembolism clinical trial?
Eligibility criteria for venous thromboembolism trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
2
Top Sponsors
Memorial Sloan Kettering Cancer Center 1 trial
Stanford University 1 trial
China-Japan Friendship Hospital 1 trial
Diagnostica Stago R&D 1 trial
Arianna Anticoagulazione Foundation 1 trial

Recruiting Clinical Trials

NCT07399977
Recruiting
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
Enrollment
259 pts
Location
United States, Austr...
Sponsor
Memorial Sloan Kettering Cance...
View Trial →
NCT01158482
Recruiting
Filter Initial & Long Term Evaluation After Placement and Retrieval Registry
Enrollment
5,000 pts
Location
United States
Sponsor
Stanford University
View Trial →
NCT04211181
Recruiting
CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism
Enrollment
5,800 pts
Location
China
Sponsor
China-Japan Friendship Hospita...
View Trial →
NCT06480994
Recruiting
Exclusion of Venous Thrombo-Embolism With a New Clinical Decision Support
Enrollment
1,836 pts
Location
France
Sponsor
Diagnostica Stago R&D
View Trial →
NCT04257487 Phase 3
Recruiting
Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)
Enrollment
1,455 pts
Location
Italy
Sponsor
Arianna Anticoagulazione Found...
View Trial →
NCT06861088 Phase 3
Recruiting
The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer
Enrollment
480 pts
Location
United States
Sponsor
Quercis Pharma AG
View Trial →
NCT06372730
Recruiting
Residual Pulmonary Vascular Obstruction Index Computed With Ventilation/Perfusion SPECT/CT Imaging to Predict the Risk of Venous Thromboembolism Recurrence in Patients With Pulmonary Embolism (PRONOSPECT)
Enrollment
665 pts
Location
France
Sponsor
University Hospital, Brest
View Trial →

Related Conditions

pulmonary embolism (3) deep venous thrombosis (2) venous thromboembolic disease (1) quality improvement (1) deep vein thrombosis (1) anticoagulant (1) elderly (1) metastatic pancreatic cancer (1) locally advanced pancreatic adenocarcinoma (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology